References

The Revised Authoritative Guide To Vaccine Legal Exemptions

Vaccines Have Serious Side Effects

Get Instant Access

1. Berkner, K. L. (1988). Development of adenovirus vectors for the expression of heterologous genes. BioTechniques 6, 616-629.

2. Chengalvala, M. V., Lubeck, M. D., Selling, B. J., Natuk, R. J., Hsu, K. H., Mason, B. B., Chanda, P. K., Bhat, R. A., Bhat, B. M., Mizutani, S., Davis, A. R., and Hung, P. P. (1991). Adenovirus vectors for gene expression. Curr. Opin. Biotechnol. 5, 718-722. [Review]

3. Graham, F. L., and Prevec, L. (1992). Adenovirus based expression vectors and recombinant vaccines. In "Vaccines: New Approaches to Immunological Problems" (R. W. Ellis, Ed.), pp. 363-390. Butterworth-Heinemann, Storeham, MA.

4. Morgan, R. A., and Anderson, W. F. (1993). Human gene therapy. Annu. Rev. Biocbem. 62, 191-217. [Review]

5. Trapnell, B. C. (1993). Adenoviral vectors for gene transfer. Adv. Drug Deliv. Rev. 12, 185-199.

6. Trapnell, B. C., and Gorziglia, M. (1994). Gene therapy using adenoviral vectors. Curr. Opin. Biotechnol. 5, 617-625. [Review]

7. Thummel, C., Tjian, R., and Grodzicker, T. (1981). Expression of SV40 T antigen under control of adenovirus promoters. Cell 23, 825-836.

8. Thummel, C., Tjian, R., and Grodzicker, T. (1982). Construction of adenovirus expression vectors by site-directed in vivo recombination./. Mol. Appl. Genet. 1, 435-446.

9. Horwitz, M. S. (1990). Adenoviridae and their replication. In "Virology" (B. N. Fields, D. M. Knipe, et al, Eds.), 2nd ed., pp. 1679-1721. Raven Press, New York.

10. Shenk, T. (1996). Adenoviridae: The viruses and their replication. In "Virology" (B. N. Fields, D. M. Knipe, P. M. Howley, et al., Eds.), pp. 2111-2148. Raven Press, Philadelphia, PA.

11. Graham, F. L., Smiley, J., Russell, W. C., and Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. /. Gen. Virol. 36, 59-74.

12. Fallaux, F. J., Bout, A., van der Velde, I., van den Wollenberg, D. J., Hehir, K. M., Keegan, J., Auger, C., Cramer, S. J., van Ormondt, H., van der Eb, A. J., Valerio, D., and Hoeben, R. C. (1998). New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 9, 1909-1917.

13. Armentano, D., Zabner, J., Sacks, C., Sookdeo, C. C., Smith, M. P., St. George, J. A., Wadsworth, S. C., Smith, A. E., and Gregory, R. J. (1997). Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. /. Virol. 71, 2408-2416.

14. Armentano, D., Smith, M. P., Sookdeo, C. C., Zabner, J., Perricone, M. A., St George, J. A., Wadsworth, S. C., and Gregory, R. J. (1999). E40RF3 requirement for achieving long-term transgene expression from the cytomegalovirus promoter in adenovirus vectors. /. Virol. 73, 7031-7034.

15. Brough, D. E., Hsu, C., Kulesa, V. A., Lee, G. M., Cantolupo, L. J., Lizonova, A., and Kovesdi, I. (1997). Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo. ]. Virol. 71, 9206-9213.

16. Dedieu, J. F., Vigne, E., Torrent, C., Jullien, C., Mahfouz, I., Caillaud, J. M., Aubailly, N., Orsini, C., Guillaume, J. M., Opolon, P., Delaere, P., Perricaudet, M., and Yeh, P. (1997). Long-term gene delivery into the livers of immunocompetent mice with El/E4-defective adenoviruses./. Virol. 71,4626-4637.

17. Engelhardt, J. F., Ye, X., Doranz, B., and Wilson, J. M., (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.

18. Gao, G. P., Yang, Y., and Wilson, J. M. (1996). Biology of adenovirus vectors with El and E4 deletions for liver-directed gene therapy./. Virol. 70, 8934-8943.

19. Gorziglia, M. I., Kadan, M. J., Yei, S., Lim, J., Lee, G. M., Luthra, R., and Trapnell, B. C. (1996). Elimination of both El and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy. / Virol. 70, 4173-4178.

20. Lusky, M., Christ, M., Rittner, K., Dieterle, A., Dreyer, D., Mourot, B., Schultz, H., Stoeckel, F., Pavirani, A., and Mehtali, M. (1998). In vitro and in vivo biology of recombinant adenovirus vectors with El, E1/E2A, or E1/E4 deleted./. Virol. 72, 2022-2032.

21. Lusky, M., Grave, L., Dieterle, A., Dreyer, D., Christ, M., Ziller, Ch., Fuerstenberger, P., Kintz, J., AliHadji, D., Pavirani, A., and Mehtali, M. (1999). Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: Requirement for E4 Orf3. /. Virol. 73, 8308-8319.

22. Morral, N., W., O'Neal, H., Zhou, C., Langston, and Beaudet, A. (1997). Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors. Hum. Gene Ther. 8, 1275-1286.

23. O'Neal W. K, H. Zhou, N. Morral, E. Aguilar-Cordova, J. Pestaner, C. Langston, B. Mull, Y. Wang, A. L. Beaudet, and Lee, B. (1998). Toxicological comparison of E2a-deleted and first generation adenoviral vectors expressing a 1-antitrypsin after systemic delivery. Hum. Gene Ther. 9, 1587-1598.

24. Wang, Q., Greenburg, G., Bunch, D., Farson, D., and Finer, M. H. (1997). Persistent transgene expression in mouse liver following in vivo gene transfer with a delta El/delta E4 adenovirus vector. Gene Ther. 4, 393-400.

25. Yeh, P., Dedieu, J. F., Orsini, C., Vigne, E., Denefle, P., and Perricaudet, M. (1996). Efficient dual transcomplementation of adenovirus El and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J. Virol. 70, 559-565.

26. Christ, M., Louis, B., Stoeckel, F., Dieterle, A., Grave, L., Dreyer, D., Kintz, J., AliHadji, D., Lusky, M., and Mehtali, M. (2000). Modulation of the inflammatory properties and hepatotoxicity of recombiant adenovirus vectors by the viral E4 gene products. Hum. Gene Ther. 11, 415-427.

27. Grave, L., Dreyer, D., Dieterle, A., Michou, A. I., Doderer, C., Pavirani, A., Lusky, M., and Mehtali, M. (2000). Differential influence of the E4 adenoviral genes on viral and cellular promoters./. Gene Med. 2, 433-443.

28. Parks, R. J., Chen, L., Anton, M., Sankar, U., Rudnicki, M. A., and Graham, F. L. (1996). A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. USA 93, 13,565-13,570.

29. Mitani, K., Graham, F. L., Caskey, C. T., and Kochanek, S. (1995). Rescue, propagation and partial purification of helper virus-dependent adenovirus vector. Proc. Natl. Acad. Sci. USA

30. Morral, N., Parks, R. J., Zhou, H., Langston, C., Schiedner, G., Quinones, J., Graham, F. Lā€ž Kochanek, S., and Beaudet, A. L. (1998). High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha 1-antitrypsin with negligible toxicity. Hum. Gene Ther.

10, 2709-2716.

31. Schiedner, G., Morral, N., Parks, R. J., Wu, Y., Koopmans, S. C., Langston, C., Graham, F. L., Beaudet, A. L.and Kochanek, S. (1998). Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18, 180-183.

32. Stow, N. D. (1991). Cloning of a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis. /. Virol. 37, 171-180.

33. Berkner, K. L., and Sharp, P. A. (1983). Generation of adenovirus by transfection of plasmids. Nucleic Acids Res. 11, 6003-6020.

34. Gilardi, P., Courtney, M., Pavirani, A., and Perricaudet, M. (1990). Expression of human alpha 1-antitrypsin using a recombinant adenovirus vector. FEBS Lett. 267, 60-62.

35. Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Paakko, P. K., Gilardi, P., Stratford-Perricaudet, L. D., and Perricaudet, M. (1991). Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252, 431-434.

36. Bett, A. J., Haddara, W., Prevec, L., and Graham, F. L. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91, 8802-8806.

37. Miyake, S., Makimura, M., Kanegae, Y., Harada, S., Sato, Y., Takamori, K., Tokuda, C., and Saito, I. (1996). Efficient generation of recombinant adenoviruses using adenovirus DNAterminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA 93,1320-1324.

38. Mittal, S. K., McDermott, M. R., Johnson, D. C., Prevec, L., and Graham F. L. (1993). Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 28, 67-90.

39. Stratford-Perricaudet, L. D., Makeh, I., Perricaudet, M., and Briand, P. (1992). Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90, 626-630.

40. Mizuguchi, H., and Kay, M. A. (1998). Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum. Gene Ther. 9, 2577-2583.

41. Mizuguchi, H., and Kay, M. A. (1999). A simple method for constructing El- and E1/E4-deleted recombinant adenoviral vectors. Hum. Gene Ther. 10, 2013-2017.

42. Souza, D. W., and Armentano D. (1999). Novel cloning method for recombinant adenovirus construction in Escherichia coli. Biotechniques 26, 502-508.

43. Imler, J. L., Chartier, C., Dieterle, A., Dreyer, D., Mehtali, M., and Pavirani A. (1995). An efficient procedure to select and recover recombinant adenovirus vectors. Gene Ther. 2, 263-268.

44. Schaack, J., Langer, S., and Guo, X. (1995). Efficient selection of recombinant adenoviruses by vectors that express beta-galactosidase. /. Virol. 69, 3920-3923.

45. Davis, A. R., Meyers, K., and Wilson, J. M. (1998). High throughput method for creating and screening recombinant adenoviruses. Gene Ther. 5, 1148-1152.

46. Davis, A. R., Wivel, N. A., Palladino, J. L., Tao, L., and Wilson, J. M. (2000). Construction of adenoviral vectors. Methods Mo/. Biol. 135, 515-523.

47. Gosh-Choudhury, G., Haj-Ahmad, Y., Brinkley, P., Rudy, J., and Graham F. L. (1986). Human adenovirus cloning vectors based on infectious bacterial plasmids. Gene 50, 161-171.

48. Ketner, G., Spencer, F., Tugendreich, S., Connelly, C., and Hieter, P. (1994). Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone. Proc. Natl. Acad. Sci. USA 91, 6186-6190.

49. Rothstein, R. (1991). Targeting, disruption, replacement, and allele rescue: integrative DNA transformation in yeast. Methods Enzymol. 194, 281-301.

50. Degryse, E., Dumas, B., Dietrich, M., Laruelle, L., and Achstetter, T. (1995). In vivo cloning by homologous recombination in yeast using a two-plasmid-based system. Yeast 11, 629-640.

51. Bubeck, P., Winkler, M., and Bautsch, W. (1993). Rapid cloning by homologous recombination in vivo. Nucleic Acids Res. 21, 3601-3602.

52. Oliner, J. D., Kinzler, K. W., and Vogelstein, B. (1993). In vivo cloning of PCR products in E. coli. Nucleic Acids Res. 21, 5192-5197.

53. Kowalczykowski, S. C. (2000). Initiation of genetic recombination and recombination-dependent replication. Trends Biochem. Sci. 4, 156-165. [Review]

54. McKittrick, N. H., and Smith, G. R. (1989). Activation of Chi recombinational hotspots by RecBCD-like enzymes from enteric bacteria. ]. Mol. Biol. 210, 485-495.

55. Lorenz, M. G., and Wackernagel, W. (1994). Bacterial gene transfer by natural genetic transformation in the environment. Microbiol. Rev. 58, 563-602.

56. Smith, G. R. (1987). Mechanism and control of homologous recombination in Escherichia coli. Anrtu. Rev. Genet. 21, 179-201. [Review]

57. Hanahan, D. (1983). Studies on transformation of Escherichia coli with plasmids. /. Mol. Biol. 166, 557-580.

58. Takahashi, N. K., Yamamoto, K., Kitamura, Y., Luo, S.-Q., Yoshikura, H.and Kobayashi, I. (1992). Nonconservative recombination in Escherichia coli. Proc. Natl. Acad. Sei. USA 89, 5912-5916.

59. Degryse, E. (1995). Evaluation of Escherichia coli recBC sbcBC mutants for cloning by recombination in vivo./. Biotechnol. 39, 181-187.

60. Chartier, C., Degryse, E., Gantzer, M., Dieterle, A., Pavirani, A., and Mehtali, M. (1996). Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70, 4805-4810.

61. Castro-Peralta, F., and Villarreal, L. P. (2000). The use of oligonucleotide directed cleavage of DNA and homologous recombination in the production of large recombinant adenoviral vectors. Gene Ther. 7, 583-586.

62. Crouzet, J., Naudin, L., Orsini, C., Vigne, E., Ferrero, L., Le Roux, A., Benoit, P., Latta, M., Torrent, C., Branellec, D., Denefle, P., Mayaux, J. F., Perricaudet, M., and Yeh, P. (1997). Recombinational construction in Escherichia coli of infectious adenoviral genomes. Proc. Natl. Acad. Sei. USA 94, 1414-1419.

63. He, T. C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., and Vogelstein, B. (1998). A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sei. USA 95, 2509-2514.

64. Hanahan, D., and Gluzman, Y. (1984). Rescue of functional replication origins from embedded configurations in a plasmid carrying the adenovirus genome. Mol. Cell. Biol. 4, 302-309.

65. Lathe, R., Villotte, J. L., and A.J. Clark. (1987). Plasmid and bacteriophage vectors for excision of intact inserts. Gene 57, 193-201.

66. Degryse, E. . (1996). In vivo intermolecular recombination in Escherichia coli: application to plasmid constructions. Gene 170, 45-50.

67. Leissner, P., Legrand, V., Schlesinger, Y., AliHadji, D., van Raaij, M., Cusack, S., Pavirani, A., and Mehtali, M. (2000). Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism. Gene Ther. 8, 49-57.

68. Colleaux, L., d'Auriol, L., Betermier, M., Cottarel, G., Jacquier, A., Galibert, F., and Dujon, B. (1986). Universal code equivalent of a yeast mitochondrial intron reading frame is expressed into E. coli as a specific double strand endonuclease. Cell 28, 521ā€”33.

69. Marinus, M. G. (1996). Methylation of DNA. In "Escherichia coli and Salmonella: Cellular and Molecular Biology" (F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S.Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger, Eds.), 2nd ed., pp. 782-791. ASM Press, Washington, DC.

70. Perlman, P. S.and Butow, R. A. (1989). Mobile introns and intron-encoded proteins. Science 246, 1106-1109.

71. Watt, V. M., Ingles, C. J., Urdea, M. S., and Rutter, W.J. (1985). Homology requirements for recombination in Escherichia coli. Proc. Natl. Acad. Sei. USA 82, 4768-4772.

72. Cohen, A., and Clark, A. J. (1986). Synthesis of linear plasmid multimers in Escherichia coli K-12. /. Bacteriol. 167, 327-335.

73. Grant, S. G., Jessee, J., Bloom, F. R., and Hanahan, D. (1990). Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants. Proc. Natl. Acad. Sei. USA 87, 4645-4659.

74. Zakhartchuk, A. N., Reddy, P. S., Baxi, M., Baca-Estrada, M. E., Mehtali, M., Lorne A. Babiuk, L. A., and Tikoo, S. K. (1998). Construction and characterization of E3-deleted

Bovine adenovirus Type 3 expressing full-length and truncated form of bovine Herpesvirus type 1 glycoprotein gD. Virology 250, 220-229.

75. Reddy, P. S., Idamakanti, N., Hyun, B. H., Tikoo, S. K., and Babiuk, L. A. (1999). Development of porcine adenovirus-3 as an expression vector. }. Gen. Virol. 80, 563-570.

76. van Olphen, A. L., and Mittal, S. K. (1999). Generation of infectious genome of bovine adenovirus type 3 by homologous recombination in bacteria. /. Virol. Methods 77, 125-129.

77. Michou, A. I., Lehrmann, H., Saltik, M., and Cotten, M. (1999). Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors. /. Virol. 73, 1399-1410.

78. Fujita-Kusano, A., Naito, Y., Saito, I., and Kobayashi, I. (2000). Mutation correction by homologous recombination with an adenovirus vector. Methods Mol. Biol. 133, 101-109.

79. Stachel, S., An, G., Flores, C., and Nester, E. (1985). A Tn3 lacZ transposon for the random generation of beta-galactosidase gene fusions: Application to the analysis of gene expression in Agrobacterium EMBO J. 4, 891-898.

80. Ditta, G., Schmidhauser, T., Yakobson, E., Lu, P., Liang, X. W., Finlay, D. R., Guiney, D., and Helinski, D. R. (1985). Plasmids related to the broad host range vector, pRK290, useful for gene cloning and for monitoring gene expression. Plasmid 13, 149-153.

81. Thomas, C., and Smith, C. (1987). Incompatibility group P plasmids: genetics, evolution, and use in genetic manipulation. Annu. Rev. Microbiol. 41, 77-101.

82. Bloomfield, I. C., Vaughn, V., Rest, R. F., and Eisenstein, B. I. (1991). Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSClOl replicon. Mol. Microbiol. 5, 1447-1457.

83. Richards, C. A., Brown, Ch. E., Cogswell, J. P., and Weiner, M. P. (2000). The admid system: Generation of recombinant adenoviruses by Tn7-mediated transposition in E. coli. Biotechniques 29, 146-154.

84. Marshall, P., and Lemieux, C. (1992). The I-Ceul endonuclease recognizes a sequence of 19 base pairs and preferentially cleaves the coding strand of the Chlamydomonas moewusii chloroplast large subunit rRNA gene. Nucleic Acids Res. 20, 6401-6407.

85. Gimble, F. S., and Thorner J. (1992). Homing of a DNA endonuclease gene by meiotic gene conversion in Saccharomyces cerevisiae. Nature 357, 301-306.

Was this article helpful?

0 0

Post a comment